Overview
Migratory polyarthritis refers to arthritis that affects multiple joints and can be associated with various underlying conditions, including inflammatory rheumatic diseases and metabolic disorders. Accurate diagnosis is crucial for appropriate management and treatment 2.Diagnosis
Clinical Presentation: Evaluate for symmetrical or asymmetrical joint involvement and duration of symptoms 2.
Laboratory Tests: Utilize markers of inflammation (e.g., ESR, CRP) to differentiate inflammatory from non-inflammatory causes 2.
Serological Testing: Perform targeted serological tests based on clinical suspicion (e.g., anti-citrullinated protein antibody (ACPA), rheumatoid factor) rather than comprehensive panels 2.
Imaging: Consider musculoskeletal imaging modalities such as ultrasonography, MRI, and DECT for detailed joint assessment 2.
Synovial Fluid Analysis: Limited role; primarily useful in specific contexts 2.Management
First-Line Treatments:
- Anti-inflammatory Medications: Nonsteroidal anti-inflammatory drugs (NSAIDs) for symptomatic relief 2.
- Disease-Modifying Antirheumatic Drugs (DMARDs): For inflammatory conditions like rheumatoid arthritis, consider methotrexate or other DMARDs 2.
Adjunctive Treatments:
- Biologic Agents: For refractory cases, biologic DMARDs targeting specific cytokines (e.g., TNF inhibitors) may be necessary 2.
- Physical Therapy: To maintain joint function and mobility 2.Special Populations
Pediatrics: Limited evidence; focus on social determinants of health affecting access to care and preventive services 1.
Comorbidities: No specific guidance provided in abstracts; manage based on individual comorbidities 2.Key Recommendations
Tailor serological testing to clinical suspicion rather than using comprehensive arthritis panels to improve diagnostic accuracy (Evidence: Moderate 2).
Utilize a combination of clinical evaluation, laboratory markers, and imaging to differentiate between inflammatory and non-inflammatory causes of migratory polyarthritis (Evidence: Moderate 2).
Address social determinants of health, particularly in pediatric migrant populations, to improve healthcare access and preventive care utilization (Evidence: Expert opinion 1).References
1 Carreño Calderon A, Blukacz A, Cabieses B, Obach A, Ortega A. Health conditions of migrant children and adolescents from Latin America and Caribe: A narrative review. Medwave 2024. link
2 Kumar A. How to investigate new-onset polyarthritis. Best practice & research. Clinical rheumatology 2014. link
3 Romeuf M, Rémy C. Early immunohistochemical detection of somatostatin-like and methionine-enkephalin-like neuropeptides in the brain of the migratory locust embryo. Cell and tissue research 1984. link